CD209 and COVID-19: Although we highlighted hACE2 as a binding partner of SARS-CoV-2, a number of studies presented different docking partners of the human host to SARS-CoV-2 infections, such as NRP1, L-SIGN(CLEC4M), DC-SIGN(CD209), and CD147(BSG) [27–30].